Ciprofloxacin
Product Images NDC 12634-769

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 12634-769). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotheca Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (769 80)

The text seems to be a description of a medication named Ciprofloxacin, which comes in 500mg tablets packaged in bottles containing 20 tablets. The medication has a NOC number and an expiration date. The tablets are manufactured by a certain company and distributed by Apotheca Inc, Phoenix, AZ. The packaging is tight and light-resistant with a child-resistant closure. The text includes instructions for use, storage, and a note to call a physician for medical advice in case of side effects. However, some of the text is not easy to understand, and some parts are illegible.*

FDA Label Image

Ciprofloxacin Chemical Structure (Ciprofloxacin Tablets 1)

FDA Label Image

Table 1 (Ciprofloxacin Tablets 2)

Table 1 presents the susceptibility test interpretive criteria for Ciprofloxacin against various bacteria. It lists the MIC (minimum inhibitory concentration) values and the corresponding diameter measures for each type of bacteria. The results are categorized as susceptible, intermediate, or resistant. The absence of data on resistant isolates precludes defining any other result than susceptible, and isolates that yield MIC result other than susceptible should be submitted to a reference laboratory for further testing.*

FDA Label Image

Table2 (Ciprofloxacin Tablets 3)

This is a table showing the quality control results for susceptibility testing of ciprofloxacin on different strains of bacteria including Enterococcus faecalis, Escherichia coli, Hemophilus influenzae, Pseudomonas aeruginosa, Staphylococcus aureus, Neisseia gonorrhoeae, and C. jejuni. The table shows the MIC range and zone diameter in millimeters for each strain. Testing methods varied between agar environment and broth microdilution procedure using different growth supplements and CO2 percentages.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.